NYSE$CL
Colgate-Palmolive · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Net sales and organic sales increased, while GAAP EPS declined due to pressure from raw and packaging material costs.
Colgate-Palmolive reported an 8.5% increase in net sales and a 10.0% increase in organic sales for Q1 2023. GAAP EPS decreased by 32% to $0.45, while Base Business EPS declined by 1% to $0.73. The company's strategy to accelerate growth is showing positive momentum, with improvements in net and organic sales growth, gross profit margin, advertising spending, operating profit, and free cash flow.
- Net sales increased by 8.5% and organic sales grew by 10.0% with growth in every division and in all four categories.
- GAAP EPS declined 32% to $0.45; Base Business EPS declined 1% to $0.73.
- GAAP Gross profit margin and Base Business Gross profit margin both decreased 160 basis points to 56.9%, including a negative 90 basis point impact from private label sales resulting from the previously disclosed acquisitions of pet food businesses.
- Net cash provided by operations was $735 million for the first three months of 2023.
Headline financials
Revenue & EPS history
Colgate · Revenue · Quarterly
$4.77B
Revenue by segment
Colgate · $4.77B total across 6 segments · Q1 2023
- OPHC Latin America$1.08B+12.7%22.5%
- Pet Nutrition$1.06B+21.7%22.2%
- OPHC North America$958M+3.5%20.1%
- OPHC Asia Pacific$738M+1.7%15.5%
- OPHC Europe$650M-0.6%13.6%
- OPHC Africa/Eurasia$288M+7.9%6.0%
Forward guidance
The Company now expects net sales growth to be 3% to 6% including the benefit from our acquisitions of pet food businesses and a low-single-digit negative impact from foreign exchange. The Company now expects organic sales growth to be 4% to 6%. On a GAAP basis, the Company still expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth. On a non-GAAP (Base Business) basis, the Company still expects gross profit margin expansion and increased advertising investment and now expects mid-single-digit earnings-per-share growth.
Tailwinds
- Net sales growth expected to be 3% to 6% including the benefit from acquisitions of pet food businesses.
- Organic sales growth expected to be 4% to 6%.
- Gross profit margin expansion is still expected on a GAAP basis.
- Increased advertising investment is still expected on a GAAP basis.
- Double-digit earnings-per-share growth is still expected on a GAAP basis.
Headwinds
- Low-single-digit negative impact from foreign exchange is expected.
- Uncertainty in the global operating environment, particularly in the back half of the year.
- Continued pressure from raw and packaging material costs.
- Gross profit margin decreased 160 basis points to 56.9%.
- GAAP EPS declined 32%.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
-0.4%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+1.0%
Avg return
30 days after
42%
31 / 73 earnings
Positive
+8.0%
Q4 2025
Best reaction
-9.3%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.2% | +3.3% | +5.7% | |
| Q4 2025 | +8.0% | +10.7% | +16.3% | |
| Q3 2025 | -2.0% | +0.5% | +5.1% | |
| Q2 2025 | -0.4% | +0.9% | +0.3% | |
| Q1 2025 | +1.3% | -0.6% | -0.1% | |
| Q4 2024 | -4.6% | +1.9% | +1.8% | |
| Q3 2024 | -4.0% | -5.1% | -4.8% | |
| Q2 2024 | +4.5% | +2.8% | +8.0% | |
| Q1 2024 | +1.3% | +2.9% | +4.5% | |
| Q4 2023 | +3.4% | +3.7% | +6.2% | |
| Q3 2023 | +1.1% | +2.5% | +5.8% | |
| Q2 2023 | -1.1% | +0.6% | -4.3% | |
| Q1 2023 | +3.5% | +4.3% | -2.2% | |
| Q4 2022 | -3.5% | -0.7% | -3.2% | |
| Q3 2022 | +0.8% | -0.6% | +4.8% | |
| Q2 2022 | +2.4% | +2.8% | +0.0% | |
| Q1 2022 | -7.4% | -5.2% | -2.9% | |
| Q4 2021 | -0.3% | +0.1% | -5.5% | |
| Q3 2021 | -1.2% | +0.5% | +0.2% | |
| Q2 2021 | -4.8% | -6.3% | -7.3% | |
| Q1 2021 | +1.6% | +1.9% | +5.0% | |
| Q4 2020 | -0.8% | -0.3% | -5.0% | |
| Q3 2020 | +4.6% | +9.4% | +10.7% | |
| Q2 2020 | -0.4% | -0.9% | +3.3% | |
| Q1 2020 | -1.1% | -3.5% | +2.9% | |
| Q4 2019 | +7.9% | +9.0% | -2.7% | |
| Q3 2019 | -4.7% | -3.0% | -1.1% | |
| Q2 2019 | +5.1% | -0.3% | +0.4% | |
| Q1 2019 | +3.9% | +3.8% | +3.7% | |
| Q4 2018 | +0.9% | +2.8% | +7.6% | |
| Q3 2018 | -9.3% | -6.7% | -3.2% | |
| Q2 2018 | -0.7% | -1.3% | -0.1% | |
| Q1 2018 | -2.0% | -5.2% | -4.3% | |
| Q4 2017 | -4.6% | -4.0% | -9.1% | |
| Q3 2017 | -2.8% | -0.9% | +1.1% | |
| Q2 2017 | -0.3% | +1.3% | -1.5% | |
| Q1 2017 | -2.0% | -3.0% | +2.9% | |
| Q4 2016 | -5.4% | -5.2% | +7.5% | |
| Q3 2016 | -0.1% | -0.4% | -6.6% | |
| Q2 2016 | +1.6% | +2.2% | +1.6% | |
| Q1 2016 | +2.3% | — | — | |
| Q4 2015 | +1.8% | — | — | |
| Q3 2015 | -2.5% | — | — | |
| Q2 2015 | -1.3% | — | — | |
| Q1 2015 | -1.2% | — | — | |
| Q4 2014 | +3.7% | — | — | |
| Q3 2014 | +1.6% | — | — | |
| Q2 2014 | -3.3% | — | — | |
| Q1 2014 | +2.2% | — | — | |
| Q4 2013 | -0.6% | — | — | |
| Q3 2013 | +0.2% | — | — | |
| Q2 2013 | +3.0% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2012 | -0.9% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | +4.8% | — | — | |
| Q1 2012 | -1.2% | — | — | |
| Q4 2011 | +0.2% | — | — | |
| Q3 2011 | +0.8% | — | — | |
| Q2 2011 | -1.3% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q4 2010 | -0.6% | — | — | |
| Q3 2010 | +2.1% | — | — | |
| Q2 2010 | -5.8% | — | — | |
| Q1 2010 | -1.1% | — | — | |
| Q1 2009 | -1.1% | — | — | |
| Q4 2009 | -0.0% | — | — | |
| Q3 2008 | +1.2% | — | — | |
| Q3 2009 | +1.2% | — | — | |
| Q2 2009 | -4.5% | — | — | |
| Q4 2007 | -4.5% | — | — | |
| Q2 2008 | -4.5% | — | — | |
| Q4 2008 | -4.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro